Forging the most promising paths to your success

Communication of the value of a product to key stakeholders is done through market shaping initiatives. Our teams utilize extensive experience to develop P&R strategies and commercially meaningful value arguments across a broad range of therapy areas.

What sets the Certara approach apart?

Our offering stands out as a unique marriage of analytics on the data in real world settings with proven payer strategy on how to best leverage that evidence for reimbursement success.  Our focus on value demonstration and evidence development is driven by your product’s real world impact, not its clinical trial results.

In our work with small and large companies as well as for investors, we know that every step matters and that time is of the essence. As a strategic market access partner, we assess the most promising paths to your commercial success.

Early value assessment

Success in the life sciences marketplace is the result of objective, insightful, and accurate assessments of early-stage innovations, followed by comprehensive commercial planning and execution support.

Certara works with healthcare innovators to strategically optimize their market value in the context of financing or partnering deals. Our services include:

  • Full asset valuation
  • Target patient population selection
  • Clinical development strategy
  • Competitive landscape analysis
  • Early revenue and pricing development
  • Preparation and participation in investor and partner meetings
Contact us
Value frameworks and ICER value assessments

Demands on the certainty of real world performance are increasing, spurring use of structured frameworks to assess clinical and economic value of therapies.

We conduct standard economic and disease modeling, as well as advanced Bayesian decision-modeling.  We also investigate value frameworks to support a multi-dimensional assessment of technologies, supporting transparent and participatory deliberations and decision making.

In preparing for Institute for Clinical and Economic Review (ICER) reviews, we recommend a holistic and simultaneous evidence and value strategy. Our “ICER support” is rooted in superior modeling and data generation to highlight potential areas of scientific disagreement with the organizations’ approach and unveil more appropriate evidence capture.

Download brochure
Your compelling Global Value Dossier (GVD)

Global Value Dossier is a single source compendium of information developed and gathered over the life cycle.

We use a structured approach to evaluate, synthesize, and translate evidence into a compelling value dossier underpinned by industry HTA standards and in-house methodologies derived from multi-criteria decision analysis.

Start a conversation
Back to top